News
Right now one of the best healthcare stocks to look at is medical device giant Medtronic ( MDT 0.39%), which is offering a ...
17h
GlobalData on MSNFirst subject enrolled in trial of Medtronic’s liquid embolic systemMedtronic has announced the first subject enrolment in the Peripheral Onyx Liquid Embolic (PELE) trial. The study aims to ...
Medtronic, a leading Healthcare Technology company, announces a partnership with world number 3 tennis player Alexander ...
2d
GlobalData on MSNMedtronic’s Hugo robot wins CE mark for vessel-sealing technologyWith EU CE mark clearance for LigaSure RAS, Medtronic expands the Hugo system’s capabilities in gynaecologic and urologic ...
Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).
Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...
Medtronic announced today that it received CE mark for its LigaSure vessel sealing technology for use with its Hugo system.
CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Medtronic on July 15 and set a price target of $101.00. The company’s shares closed yesterday at $89.78. Take advantage of TipRanks ...
Used for diagnosing gastroesophageal reflux, the devices may not attach or detach correctly, potentially causing serious ...
However, in the postreform healthcare world where there are higher hurdles for securing reimbursement for next-generation technology, Medtronic has had to move in the direction of introducing ...
Medtronic reported that it has begun testing an expansion of its renal denervation approach for dropping stubbornly high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results